Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2561-2570 of 2762 for

Edit search filters
  1. Evaluating Intestinal Microbiome and Immune Function in Lymphoma

    Rochester, MN

  2. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM)

    Rochester, MN, Scottsdale/Phoenix, AZ

  3. Incidence of Chemotherapy and Targeted Therapy-Related Nasal Vestibulitis

    Rochester, MN

  4. A Study to Learn More About Using Different Markers to Assess Kidney Function in Patients Before and After Methotrexate Therapy

    Rochester, MN

  5. Biospecimen Resource for Hepatocellular Carcinoma Research

    Jacksonville, FL

  6. A Study to Develop a Screening Method to Provide Early Detection of HPV-associated Oropharyngeal Squamous Cell Carcinoma (OSCC)

    Jacksonville, FL

  7. A Study of MicroRNAs in Patients with Multiple Myeloma Treaded with Immunomodulatory Drugs

    Scottsdale/Phoenix, AZ

  8. Metastatic Tumor Research and Outcomes Network

    Rochester, MN

  9. Follow-up Letters for Subjects in the IRB# 13-001285 "Mayo Clinic Experience with Subjects Diagnosed with Diffuse Large B-cell Lymphoma (DLBCL)" Study

    Rochester, MN

  10. A Study of Blood and Tissue Samples to Measure Immune Responses to Melanoma

    Rochester, MN

.

Mayo Clinic Footer